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Cytokines and Inflammatory Pathways in the Pathogenesis of Multiple
Organ Failure Following Abdominal Aortic Aneurysm Repair
M. J. Bown∗, M. L. Nicholson, P. R. F. Bell and R. D. Sayers
Department of Surgery, University of Leicester, U.K.
Multiple organ failure is a common mode of death following abdominal aortic aneurysm repair, particularly after rupture.
Cytokines are the principal mediators of the inflammatory response to injury and high levels of circulating cytokines have
been associated with poor outcome in major trauma and sepsis. Abdominal aortic aneurysm repair results in an ischaemia-
reperfusion injury to the tissues distal to the site of aortic clamping. The inflammatory response in these tissues causes
the release of cytokines, principally Interleukins 1-beta, 6, and 8, and Tumour Necrosis Factor alpha. If released in large
enough concentrations, these cytokines may enter the circulation and gain access to organs distant to the site of initial
injury. Circulating cytokines cause dysfunction of the renal, cardiovascular, respiratory, nervous and musculo-skeletal
systems. The combination of these individual changes in organ function is the multiple-organ dysfunction syndrome,
which may progress to multiple organ failure.
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Introduction This paper reviews the role of cytokines in the
pathophysiology of MODS following AAA repair with
Death following repair of ruptured abdominal aortic particular reference to how individual organs injured
by AAA repair contribute to the overall inflammatoryaneurysms (AAA) is usually due to multiple organ
failure.1,2 Ischaemia-reperfusion injury following aortic response to surgery and how circulating cytokines
cause dysfunction of major organ systems.cross-clamping leads to activation of inflammatory
pathways, resulting in injury to distant organs such as
the lungs and kidneys which may initially dysfunction
and eventually fail. Methods
Multi-organ dysfunction syndrome (MODS) was ori-
ginally described in association with infective insults A systematic search of the Medline (1966 to December
but a similar syndrome is seen in patients with no 2000) and Embase (1980 to December 2000) electronic
infective focus such as trauma victims and those re- databases were performed by one of the authors (MJB).
covering from major surgery. This has been termed The Ovid search engine (version 7.8) was employed.
the systemic inflammatory response syndrome (SIRS)3 Searches based on the intersection of the MeSH key-
and the widespread activation of inflammatory word cytokine with the following keywords were
cascades has been implicated in its genesis. Cytokines examined: aortic aneurysm, abdominal; multiple organ
are the major mediators of this response and exert failure; reperfusion injury; brain; lung; heart; liver;
local and distant effects.4 SIRS is often seen in renal; ‘‘gastrointestinal system’’; ‘‘musculoskeletal sys-
patients following AAA repair and increased levels of tem’’. In addition, manual searching of reference lists
circulating cytokines have been observed in these from articles retrieved by electronic searching was
patients.5,6 used to identify articles missed by the electronic
searches. Articles retrieved were restricted to those
∗ Please address all correspondence to: M. J. Bown, Department of published in English. Articles were selected for in-Surgery, University of Leicester, Leicester General Hospital, Gwen-
dolen Road, Leicester, LE5 4PW, U.K. clusion if they concerned the production of cytokines
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Table 1. The Systemic Inflammatory Response Syndrome (SIRS).by tissues subjected to ischaemia-reperfusion injury
by AAA repair or if they gave details of the effect of
Two or more of the following:circulating cytokines on any organ system. Temperature >38 °C or <36 °C
Heart rate >90 beats/minute
Respiratory rate >20 breaths/minute or PaCO2 <4.3 kPa
WBC >12 000 cells/mm3 or <4000 cells/mm3, or >10%
immature (band) formThe injury of AAA repair
Aortic cross clamping is the significant insult during
AAA repair. The incidence of major complications and similar to that in victims of trauma.24 This led to the
death following AAA repair is much greater than for theory that MOF is a result of an inflammatory/
other common procedures requiring a laparotomy for immunological response to the initial insult rather
surgical access such as a bowel resection. Although than the nature of the insult itself.
retroperitoneal AAA repair is associated with a shorter In order to identify those patients in whom these
ITU stay and a reduced degree of post-operative ileus, inflammatory responses have become activated and
the mortality and morbidity is similar to that following are at risk of developing MOF, the systemic in-
transperitoneal AAA repair.7,8 Aortic cross clamping flammatory response syndrome (SIRS) has been de-
causes ischaemia-reperfusion injury and widespread fined (Table 1). During the progression from SIRS to
activation of inflammatory pathways. For patients with MOF a patient may have not developed complete
ruptured aortic aneurysm there are the additional organ failure but individual organ systems may be
insults of haemorrhage, acidosis and blood trans- functioning abnormally. Multiple organ dysfunction
fusion. This so called ‘‘second hit’’ phenomenon causes syndrome (MODS) has been defined as the detection
further activation of inflammatory pathways. Com- of altered organ function in the acutely ill patient such
plications following AAA repair often occur in organs that homeostasis cannot be maintained.3
distant to the site of direct injury caused by aortic
clamping. This distant organ injury has been shown
to be neutrophil dependant,9 however it appears to be
due to the activation of resident neutrophils in these Cytokines
organs rather than the influx of neutrophils from the
site of injury.10 This activation of resident neutrophils Cytokines are low molecular weight glycoproteins that
must therefore be due to factors generated at the site were first identified as being produced by cells of the
of surgical injury passing in the circulation to these immune system and involved in the regulation of
distant organs. immune system responses and intercellular signalling.
Recently other cell types such as fibroblasts, smooth
muscle cells and endothelial cells have been recognised
as capable of cytokine production.25–29Multi-organ failure and SIRS
In the most part, cytokines act via paracrine and
autocrine routes. For example, when an antigen bindsMulti-organ failure (MOF) was first described in
patients who had undergone emergency repair of a to MHC class II receptors on the surface of an antigen
presenting cell the cell becomes activated and producesruptured AAA11 and is associated with a high mor-
tality.12,13 The mortality following failure of a single Interleukin (IL)-1. This acts upon nearby T lym-
phocytes to stimulate IL-2 production and also theorgan system is around 30% and each additional organ
system failure increases the risk of death in a mul- production of IL-2 receptors. The IL-2 produced can
then act via autocrine and paracrine pathways.tiplicative fashion.14–16 The sequential failure of organ
systems over time is the defining characteristic of MOF. Cytokines are an integral part of the inflammatory
and immune responses. Absolute amounts of cytokineMOF is the most common cause of death in patients
on ITU12,17–21 and frequently presents with a syndrome production are usually very low (picomolar con-
centrations) and this limits their actions to the localresembling sepsis: pyrexia, leucocytosis, dyspnoea and
a hyperdynamic circulation. For this reason early stud- tissues. The excessive production of cytokines and
overspill into the systemic circulation is responsibleies of MOF focused on infection as the underlying
cause.16,22 However, MOF was also noted following for their role in SIRS and MODS. This effect was
originally demonstrated in animal models wherebymajor trauma where no infective aetiology could be
implicated23 and further studies revealed that the pre- injection of TNF- induced a syndrome clinically ident-
ical to shock.30,31sentation of MOF in patients with infective insults was
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Table 2. Cytokines identified during critical illness and clinical significance.
Clinical scenario Cytokines identified Significant outcome associations
Bacterial sepsis37–39 IL-10, TNF-, IL-6, Elevated IL-6, TNF-sR associated with non-survival
IL-12, TNF-sR IL-6 closely correlated with severity of illness
Intra-abdominal sepsis40 IL-6, TNF-sR, IL-1Ra Elevated IL-6 associated with non-survival
Severe sepsis/septic shock in a TNF-, IL-6, IL-8 TNF-, IL-6 and IL-8 levels higher in septic shock than severe sepsis
surgical intensive care unit41
Major trauma42,43 IL-10 Elevated IL-10 associated with incidence of sepsis/MODS
Sepsis syndrome44 TNF-, IL-1, IL-6 Elevated IL-6 associated with non-survival
The production of cytokines by cells of the in- during sepsis has, in some cases, been examined. Non-
survival has been associated with high levels of IL-6,flammatory and immune systems is triggered during
activation of the inflammatory cascades. Cytokines TNF-sR, IL-8 and IL-10 (see Table 2). High levels of pro-
inflammatory cytokines represent excess activation ofcan be broadly divided into those with primarily
pro-inflammatory actions and those with anti- the inflammatory system and SIRS. Raised IL-10 is
probably associated with mortality through itsinflammatory actions. Pro-inflammatory cytokines
such as IL-1, IL-6 and TNF- promote the further immunosuppressive effects.45 Roumen et al.5 examined
TNF-, IL-1 and IL-6 following AAA repair. Highliberation of cytokines and cause the classical signs of
inflammation. immediate post surgery levels of both IL-1 and TNF-
, and IL-1 levels at 24 hours were significantlyThe actions of pro-inflammatory cytokines are ne-
cessarily limited by auto-regulatory mechanisms. Prin- associated with increased mortality. High levels of IL-
6 correlated with the presence of adult respiratorycipal among these are the anti-inflammatory cytokines
and the very short half-lives of cytokines limiting their distress syndrome (ARDS) and a high MOF score.
Holmberg et al.6 measured IL-6, IL-10, MCP-1 andduration of action. IL-10 is a potent anti-inflammatory
cytokine. It inhibits macrophage function32 and acts soluble IL-2 receptor (sIL-2R) during, and one week
after aneurysm surgery; all were significantly elevated,indirectly on T-cells by interfering with the antigen
presenting cell signals to the T-cells.33 It reduces pro- with the greatest increase immediately after aortic
declamping. The recent systematic review by Swartbolinflammatory cytokine production by macrophages,
neutrophils and T-cells. Naturally occurring ant- et al.46 gives a complete summary of these and other
studies examining cytokine responses to AAA repair.agonists to some cytokines have also been identified.
These can be soluble receptors (TNF-sR)34 or struc-
turally related peptides with no apparent action (IL-1
receptor antagonist – IL-1Ra).35
The Generation of Cytokine Responses toWhilst TNF- is the prototypical mediator of sepsis
AAA Repairthe identification and study of other inflammatory/
immune system mediators has revealed complex inter- Aortic clamping causes an ischaemia-reperfusion (IR)actions between these mediators. The examination of injury in tissues distal to the site of the clamp. The IRindividual cytokines is largely academic. All cytokines injury in distal tissues leads to cytokine release andact as part of a network, the balance of pro- versus subsequently the clinical effects of SIRS and possiblyanti-inflammatory mediators defines the overall re- MOF.sponse. RC Bone describes this balance in terms of SIRS
and the concept of a compensatory anti-inflammatory
response syndrome (CARS).36 Predominance of SIRS
(pro-inflammatory pathways) leads to shock, apo- Distal vasculature
ptosis and organ dysfunction whilst excessive ac-
tivation of CARS (anti-inflammatory pathways) results Endothelium damaged by IR produces complement,
arachidonic acid metabolites such as prostaglandinin immune system depression.
Most cytokines are not normally detectable in E2 and thromboxane A2 and up-regulates adhesion
molecule expression (ICAM 1 and 2, VCAM 1).47healthy individuals but during critical illness elevated
levels of cytokines have been identified in many stud- Neutrophils bind to adhesion molecules via integrins
and become activated. These activated neutrophilsies (Table 2).
The clinical importance of elevated cytokine levels migrate across the endothelium and cause further local
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tissue damage by releasing lysosomal contents and IL-6 following intestinal IR64 and IL-6 knockout mice
show reduced systemic levels of TNF- and IL-1 infree radicals. Reduced nitric oxide (NO) production in
endothelium following IR48 impairs endothelial func- response to intestinal IR.65 This demonstrates the pro-
and anti-inflammatory effects of IL-6 and IL-10 re-tion and in turn vascular homeostasis. These processes
cause cytokine release via activation of neutrophils spectively.
Elevated levels of TNF- in the portal circulationand direct production of cytokines by the endothelial
and vascular smooth muscle cells themselves. Hyp- have been observed following elective AAA repair.66
The reasons for this are not clear. Animal studies haveoxia, independent of reperfusion has been shown to
induce IL-6 production by endothelial cells.49 demonstrated increased intestinal permeability after
isolated hind-limb ischaemia, suggesting that this is
mediated via factors generated in the tissues subjected
to injury which in turn exert their effects on the gastro-
Lower limbs intestinal tract.67 In humans elective aortic surgery
is associated with increased intestinal permeability
The cytokine profiles seen following isolated limb IR despite no direct IR injury to the gut and this may be
in humans have not been studied in detail. Raised IL- caused by a similar mechanism or it may be due to
1 and TNF- have been observed following tourniquet- cooling and handling of the gut during repair.68
induced limb ischaemia.50 IL-6, IL-10 and IL-1Ra51 have During elective AAA repair an IR injury may be
also been observed following traumatic and tour- sustained by the distal large bowel if it’s circulation is
niquet-induced limb ischaemia, however the effects dependant on the internal iliac system. Using intra-
of trauma in these patients may confound the true mucosal sigmoid pH monitoring Soong et al. dem-
response due to IR alone. In animals skeletal muscle onstrated that during elective AAA repair low sigmoid
IR results in the production of TNF-52 and IL-1.53 pH, indicating ischaemia, was not dependant on any
Whether this is quantitatively significant in patients intra-operative factors and also that low pH was as-
undergoing AAA repair is unclear. Holmberg et al.6 sociated with higher post-operative endotoxin, TNF-
found no difference in IL-6 and IL-10 levels between  and IL-6 concentrations.69 Higher levels of portal
femoral and cubital venous samples taken immediately endotoxaemia and larger increases in intestinal per-
after aortic de-clamping during AAA repair. meability have been observed in patients undergoing
transperitoneal AAA repair compared to retro-
peritoneal repair and this has been attributed to
manipulation of the bowel during transperitoneal re-
Gastro-intestinal tract pair.70
In ruptured AAA haemorrhagic shock causes splanch-
nic vasoconstriction which leads to intestinal hypo- Kidneys
perfusion and ischaemia. Upon resuscitation the gut
is reperfused and an IR injury is sustained. This has During the majority of elective AAA repairs supra-
renal cross-clamping of the aorta is avoided. Howeverbeen implicated in the generation of MODS.54,55 Loss
of gut barrier function occurs following intestinal IR infra renal clamping also causes renal damage and
changes in renal perfusion. Supra-renal aortic clamp-and consists of increased mucosal permeability (via
NO,56 locally acting cytokines (IL-13, IL-4, Platelet- ing is more frequently employed during emergency
surgery due to the need to gain rapid control ofActivating-Factor (PAF))57,58 and superoxide mech-
anisms59) and bacterial translocation.60 Bacterial haemorrhage. This, in addition to the insult of sig-
nificant haemorrhage results in a higher mortality duetranslocation causes localised inflammation and con-
sequently further cytokine production. Bacterial trans- to acute renal failure post-operatively.71 The cessation
or re-distribution of renal blood flow produces a totallocation also allows bacteria and endotoxin normally
contained within the gut lumen to enter the portal or partial ischaemic insult to the renal parenchyma.
Upon reperfusion the ischaemic tissue sustains an IRand systemic circulations. Elevated systemic TNF-
and portal endotoxaemia have been demonstrated in injury. Animal studies have demonstrated elevated
tissue levels of IL-1, IL-2, IL-6, TNF-, TGF- and IFN-animal models of intestinal IR.61,62 Kupffer cells in the
hepatic sinusoids are exposed to these and activated.  after renal IR.72,73
Activated Kupffer cells release cytokines, particularly
TNF-, into the circulation.63 The cytokine profiles generated by patients under-
going AAA repair are the sum of those produced byTreatment with IL-10 reduces systemic TNF- and
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the above organ injuries. The proportion that each clear. IL-10 has been shown to increase IL-6 expression
in mouse endothelial cells and potentiate the action oforgan contributes to the total is not clear.
In summary, aortic cross-clamping causes an isch- TNF- and IL-1.86 This is contradictory to its general
effects as an anti-inflammatory cytokine.aemia-reperfusion injury to distal tissues. As shown
above this injury generates cytokines in these tissues. Adhesion molecules play an integral role in endo-
thelium–leucocyte interactions. While the precise roleIf produced in large enough quantities, they may enter
the systemic circulation and if regulatory mechanisms of each different adhesion molecule is not clear,
VCAM-1 and ICAM-1 have been shown to be neces-are overwhelmed, they gain access to distant organs.
The effects of cytokines on the function of these organ sary for leucocyte adhesion.87,88 Leucocyte adhesion to
endothelium is increased in response to cytokines89systems are described below.
and this is due to cytokine mediated upregulation
of adhesion molecule expression.90–92 The anti-in-
Cytokine Effects in Distant Organ Systems flammatory effects of TGF- are partially due to the
inhibition of pro-inflammatory cytokine-stimulated
Vasculature endothelial VCAM-1 expression.93
Cardiovascular instability and in particular the loss of
normal endothelial function are prominent features
of MODS. Neutrophil-endothelial interactions sig- Respiratory system
nificantly contribute to the effects seen in distant or-
gans following IR. Cytokines have profound effects The above changes in the microcirculation are neces-
sary for neutrophil-endothelial adhesion and sub-on vascular tone, largely mediated via changes in the
nitric oxide (NO) pathway.74 As blood pressure is sequent extravasation of neutrophils, an essential step
in the normal inflammatory response. However, thedirectly related to systemic vascular resistance a drop
in vascular tone results in decreased blood pressure tissue damage caused by widespread excessive neutro-
phil activation is one of the causes of organ dysfunctionand reduced organ perfusion.
NO is produced by nitric oxide synthase (NOS) and following AAA repair. Respiratory failure is commonly
part of MODS.94 In patients suffering from adult res-is the direct mediator of vasodilatation.75 In keeping
with their pleiotropic nature different cytokines can piratory distress syndrome (ARDS) both pro- and
anti-inflammatory cytokines have been detected inhave different effects on NOS. The initial studies on
TNF- as a mediator of septic shock76 demonstrated broncho-alveolar lavage fluid.95 Circulating cytokines
in the venous circulation pass through the pulmonarythat its administration produced systemic hypotension
and other signs of septic shock although the mech- vasculature and activate both resident leucocytes and
the pulmonary vascular endothelium. The pulmonaryanisms of this response were not known. Similar re-
sponses to IL-177 have been observed and also the vasculature acts as a neutrophil pool in normal physio-
logical states and following endothelial activation,failure of response to vasoconstrictors following pro-
longed exposure to these cytokines.78,79 These two cyto- there is thus an increased potential for neutrophil–
endothelial interactions in the lungs compared withkines (TNF-, IL-1) have been shown to increase
NO production80 and also promote the production of other vascular beds. Together with the large surface
area of the pulmonary vascular endothelium thisinducible NOS (iNOS) by both endothelial and vas-
cular smooth muscle cells. Alongside the increase in means that the pulmonary vasculature is a quant-
itatively significant site of neutrophil–endothelialiNOS expression, constitutively produced endothelial
NOS (eNOS) expression is inhibited via decreased interactions.
Inflammatory pulmonary injury is caused by ac-eNOS mRNA stability.81 This leads to a change in the
site of NO production from endothelial cells to smooth tivated neutrophils and macrophages which have
migrated from the pulmonary vasculature into themuscle cells. This change in site of NO production may
facilitate adhesion molecule expression as inhibition of interstitial and alveolar spaces. Activated neutrophils
produce locally cytotoxic hypochlorous acid and oxy-cytokine-induced endothelial cell adhesion molecule
expression by NO has been demonstrated.82,83 gen free radicals.96 Macrophages secrete IL-8, IL-1 and
TNF-. Type II pneumocytes release IL-6, IL-8, G-CSFIn addition to affecting vascular function IL-1 and
TNF- also cause further cytokine release from endo- and MCP-1 in response to bradykinins97 produced by
local inflammation and further IL-8 is produced bythelial and vascular smooth muscle cells. These include
IL-6, chemokines and IL-1.29,84,85 The effects of anti- TNF- stimulation of interstitial fibroblasts.63 IL-8 is a
potent neutrophil and macrophage chemotactant andinflammatory cytokines on the vasculature are not
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thus promotes persistence of local inflammation.98 All CNS
of these responses lead to the accumulation of in-
flammatory infiltrates in the alveoli and interstitium. Early studies on cytokines demonstrated their ability
to raise body temperature, hence the previous namingThese are responsible for the decreases in gas exchange
and increased work of breathing seen in ARDS. of TNF- as endogenous pyrogen. As thermo-
regulation is under hypothalamic control cytokines
must therefore act on the CNS. Cytokines are unable
to cross the blood-brain barrier and therefore must
act in areas lacking a complete barrier such as the
Renal hypothalamus and anterior pituitary. Hypothalamic
neurons have receptors for TNF-, IL-1 and IL-6.109
Acute renal failure is commonly seen following emer- Activity in these neurons causes release of cor-
gency AAA repair, either as a part of MODS or in ticotrophin-releasing-factor (CRF) and activation of
isolation. Hypotension and supra-renal aortic clamp- the hypothalamo-pituitary-adrenal (HPA) axis with
ing cause direct injury due to ischaemia and pre- accompanying release of cortisol into the circulation.
existing chronic renal impairment exacerbates this. CRF also stimulates autonomic nuclei in the brainstem
Cytokines are known to mediate renal damage fol- and leads to subsequent endorphin release. Anterior
lowing the IR injury of transplantation. TNF- has pituitary cells possess receptors for TNF-, IL-1, IL-6,
been shown to induce glomerular injury in animals IL-2 and IFN-.110 Although the response to stimulation
without prior renal insult.99 In kidneys already dam- in these cells is unknown it would be expected to
aged by hypoperfusion or IR, cytokines can exacerbate include prolactin, growth hormone and ACTH
this injury. Glomerular cells respond to TNF- and IL- secretion.
1 by producing complement, arachidonic acid de-
rivatives, nitric oxide and oxygen free radicals.100,101
HepaticMesangial cells produce IL-1, IL-6 and IL-8 in response
to stimulation by IL-1 and IL-8.102 All of these cause The liver is the major site of acute phase proteinor increase local inflammation and further glomerular synthesis. In response to acute physiological stress theand tubular damage. liver alters its synthetic function to increase production
of acute phase proteins such as C-reactive protein
(CRP), 2-macroglobulins and serum amyloid A
(SAA). TNF-, IL-1 and particularly IL-6 stimulate
this response.111,112 This increased synthetic functionCardiac
requires increased uptake of amino-acids from the
circulation. Substrates for this are provided by in-Cardiac function is often impaired in MODS, and
creased skeletal muscle breakdown mediated by cyto-patients may require pharmacological and fluid sup-
kines – again another synonym for TNF- – cachectin.port to maintain adequate end-organ perfusion.
This response is also partially mediated by cortisol and,Patients with AAAs are at higher risk of ischaemic
as discussed above, production of cortisol increases inheart disease than the general population by virtue
response to circulating TNF-, IL-1 and IL-6.of similar risk factors and pathogenetic mechanisms
One particular group of acute phase proteins, 2-underlying both disease processes. Thus they are likely
macroglobulins, is of particular interest in referenceto have reduced cardiac reserve and are therefore
to cytokine biology. 2-Macroglobulins are capableat increased risk of cardiac complications following
of binding many different circulating cytokines. Thesurgery. IL-2 and TNF- have been shown to impair
effects of this function are unclear but it may eithercardiac function.103,104 Cytokines affect cardiac function
stabilise or prevent the action of bound cytokines oracutely through NO pathways. Cytokines act on car-
act as a transport system.113 The production of 2-diac myocytes to increase iNOS expression, leading to
macroglobulin may therefore either reduce or prolonghigher local levels of NO. NO is thought to exert its
the effects of circulating cytokines.local effects by influencing the responses of cardiac
muscle to adrenergic and cholinergic stimulation.105,106
Some cytokines (TNF-, IL-1, IL-2, IL-6, IFN-) may Clinical Sequealae
actually mediate cardiac dysfunction by direct actions
on the myocytes107,108 although the mechanisms under- Aortic cross-clamping causes an ischaemia-reperfusion
injury in tissues distal to the site of clamping and maylying these actions are not clear.
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creases renal function leading to oliguria, uraemia
and raised serum creatinine. Hypothalamic activation
causes pyrexia and HPA axis activation. The individual
organ responses are inter-related and dysfunction in
one system has a negative effect on others, causing
a vicious circle of progressively deteriorating organ
function. These clinical signs are those of SIRS and, if
significant organ dysfunction is present, MODS.
Discussion
Cytokines have been shown to potentially play a sig-
nificant role in the mediation of distant organ damage
following AAA repair and the development of MODS
(see Fig. 1). There is a great deal of evidence for
the roles of TNF-, IL-1 and IL-6 in particular. IL-6
correlates well to the degree of surgical injury and has
been demonstrated to be a useful prognostic indicator
after AAA repair.114 Although other cytokines have
not been studied in detail they may be of equal or
greater importance. Current therapeutic options in-
clude targeting the cytokines themselves and reducing
the degree of initial IR injury.
Theoretically, blocking the action of pro-inflam-
matory cytokines or administration of anti-in-
Fig. 1. Cytokine responses to AAA repair and the pathogenesis of flammatory cytokines could limit the extent of organmultiple organ dysfunction syndrome (MODS).
failure.115 Selecting single molecules, for example TNF-
116 as therapeutic targets has largely failed to achieve
any clinical effect possibly due to the pleiotropic nature
of cytokines. Compounds that have antagonistic effects
to more than one cytokine have shown benefit incause injury to those tissues supplied by braches of
the aorta immediately proximal to the site of clamping. animal studies117,118 but have not been trialed in
humans.In the case of ruptured AAA this is combined with
haemorrhagic shock and subsequent resuscitation. Open AAA repair necessarily subjects the patient to
IR. Attenuation of this pro-inflammatory stimulus hasCytokines are produced by inflammatory cells re-
cruited to these sites of damage and also by damaged been attempted by using various methods. Ischaemic
pre-conditioning has been shown to prevent systemicnative cells, most significantly endothelial cells. Re-
moving the initial stimulus may have little or no effect neutrophil activation and prevent endothelial dam-
age119 and may reduce complications in clinicalif the regulatory mechanisms have been overwhelmed
by pro-inflammatory positive feedback loops. The situations. The gastro-intestinal tract contributes sig-
nificantly to the inflammatory response to AAA repair.above demonstrates the processes involved at single
organ level but the clinical response is the combination Retroperitoneal repair obviates the need to handle
the gut and may therefore reduce the inflammatoryof these and exhibited by the patient as a whole
(Fig. 1). stimulus during AAA repair. It has been shown to
reduce neutrophil activation and SIRS, and the changesPulmonary inflammatory infiltrates increase work
of breathing and decrease gas exchange causing ta- in intestinal permeability seen using the trans-
peritioneal approach are not as marked.70,120 Clinically,chypnoea and hypoxaemia with progression to ARDS
if severe. Decreased cardiac contractility and loss of whilst several studies have shown reduced incidence
of complications after retroperitoneal repair, andvascular tone results in hypotension and decreased
organ perfusion. Decreased organ perfusion causes in particular decreased incidence of prolonged
ileus,7,8,121,122 no differences in mortality have been ob-further injury. Renal damage caused by cytokine me-
diated inflammation together with poor perfusion de- served.
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